$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
cycloserine side effects
2026-02-01 22:25:32
Check Details
Introduction to cycloserine capsules
2026-02-01 22:25:32
Check Details
Cycloserine mechanism of action
2026-02-01 22:25:32
Check Details
Cycloserine Precautions
2026-02-01 22:25:32
Check Details
Price update of Jisandai (Bingtonsha) new drug for the treatment of hepatitis C in 2024
2026-02-01 22:25:32
Check Details
The latest medical insurance reimbursement price of Jisandai (Bingtonsha) hepatitis C drug in 2024
2026-02-01 22:25:32
Check Details
Jisandai (Bingtongsha) Medical Insurance Policy Analysis and Purchasing Guide
2026-02-01 22:25:32
Check Details
Jisandai (Bingtonsha) Medical Insurance Reimbursement Policy and Purchasing Guide
2026-02-01 22:25:32
Check Details
Analysis of Domestic Purchasing Methods and Channels of Jisandai (Bingtongsha)
2026-02-01 22:25:32
Check Details
Jisandai (Bingtongsha) Domestic Price and Buying Guide
2026-02-01 22:25:32
Check Details
Can people with Parkinson's disease take rasagiline?
2026-02-01 22:25:32
Check Details
Is rasagiline suitable for the treatment of Parkinson's disease?
2026-02-01 22:25:32
Check Details
1
2
...
705
706
707
708
709
710
711
...
10211
10212
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Loargys(Pegzilarginase-nbln) Complete Medication Guide: Pre-Treatment Assessment, Monitoring and Home Administration
2
Plerixafor Complete Side Effect Guide: Adverse Reaction Classification and Professional Management
3
Selpercatinib Complete Medication Guide: Indications, Dosage and Safety Information for RET Inhibitor
4
Complete Guide to Dosage and Dose Adjustment of Entrectinib
5
Comprehensive Analysis of Bleeding Risk with Tepotinib in MET-Mutated Non-Small Cell Lung Cancer
6
Lomustine vs Temozolomide: Comprehensive Comparison of Efficacy and Safety in Glioma Treatment
7
Sopyrronium Bromide (Sofdra) for Hyperhidrosis: Uses, Mechanism and Facial Application Risks
8
Optimal Dosing Time and Medication Principles of Vigabatrin (Sabril)
9
Tepotinib and Osimertinib: Current Status and Clinical Positioning of Combination Therapy in Non-Small Cell Lung Cancer
10
Tumor Shrinkage Effect and Core Therapeutic Value of Pazopanib
11
Cabotegravir Sodium: Pioneering Long-Acting Solution for HIV Treatment and Prevention
12
Tabrecta (Capmatinib): A Targeted Therapy for METex14-Mutated NSCLC